Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
-
UPMC Data Disclosure Claims Investigated by Lynch Carpenter
-
Warmysender Reached 10000 Users, Now Support Multichannel Outreach and 20M Leads Database
-
NOV Appoints Sanjay Chowbey, President & CEO of Kennametal Inc., to the Board of Directors
-
Qfin Holdings Announces Fourth Quarter and Full Year 2025 Unaudited Financial Results and Raises Semi-Annual Dividend
-
Phoenix Energy Reports Q4 and Full-Year 2025 Financial Results with Record Revenue and EBITDA
-
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immun
-
AOI Showcases 25dBm Ultra-High Power ELSFP as the Foundation for Next-Gen AI Infrastructure at OFC 2026
-
MedPeds Data Breach Claims Investigated by Lynch Carpenter
-
Norwood Financial Corp. Announces Cash Dividend
-
Computer Resources of America Earns Place on CRN's Prestigious 2026 Tech Elite 250 List
-
Computer Resources of America Earns Place on CRN's Prestigious 2026 Tech Elite 250 List
-
Gran Tierra Energy Inc. Announces Strategic Partnership with Ecopetrol for The Development of Fields in the Middle Magdalena Valley Adjacent to Gran Tierra’s Largest Producing Field
-
Deep Sea Minerals Corp. Clarifies Disclosure at the Request of the BCSC
-
Gran Tierra Energy Inc. Provides AGM Update and Announces Board Changes
-
Coherent Demonstrates InP Technology Innovation With a Broad Range of Products
-
Marex Group plc provides details for upcoming investor day on March 26, 2026
-
Durable Launches End-to-End AI Business Platform for Entrepreneurs
-
Nuvini Announces Extension of Earnout Restructuring Deadline
-
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
-
AGF Investments Announces Pricing Reductions, Fund Terminations and Fund Merger
-
ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
-
Ashland CFO to discuss current market environment at the Gabelli Funds’ 17th Annual Specialty Chemicals Symposium
-
Ashland CFO to discuss current market environment at the Gabelli Funds’ 17th Annual Specialty Chemicals Symposium
-
Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Galapagos Receives Transparency Notification from Bank of America
-
ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting
-
Auburn National Bancorporation Authorizes Stock Repurchase Program
-
Stardust Power Reports Preliminary 2025 Results and Highlights Development Progress at Muskogee Lithium Refinery
-
ROHM has Introduced Reference Designs for Three-Phase Inverters Featuring New SiC Power Modules
-
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
-
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
-
What Should Multi-Unit Restaurant Operators Look for When Switching POS Systems? Lavu Publishes 2026 Buyer’s Guide
-
Star Equity Holdings Reports 2025 Fourth Quarter and Full-Year Results
-
Caring for the Body, PLLC Launches Physician-Led Re-Think Aging Platform to Advance a New Era of Cognitive Decline Prevention and Longevity Care
-
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026
-
Greystone Housing Impact Investors LP Schedules Fourth Quarter 2025 Earnings Conference Call and Issues Investor Schedule K-1s
-
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
-
Mr. Rooter Plumbing of North Miami Beach Surpasses 100 Google Reviews with 5-Star Rating
-
Greystone Provides $46 Million Bridge-to-HUD Loan for Seniors Housing Portfolio in Ohio
-
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
-
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
-
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
-
Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA
-
Sportradar to Participate in the 38th Annual Roth Conference
-
Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting
-
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
-
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
-
Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days
-
TransAlta Corporation Announces Conversion Results for Series A and B Preferred Shares

